Investigation of Optimal Dosage Regimen for HRS9531 Tablets in Healthy Subjects
Phase 1
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-07-17
- Last Posted Date
- 2024-07-17
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 144
- Registration Number
- NCT06506175
- Locations
- 🇨🇳
The affiliated hospital of Qingdao University, Qingdao, Shandong, China
A Trial of HRS5580 in Prevention of Postoperative Nausea and Vomiting of Adults
Phase 2
Not yet recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-26
- Last Posted Date
- 2024-06-26
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 232
- Registration Number
- NCT06475846
- Locations
- 🇨🇳
Third Xiangya Hospital of Central South University, Changsha, Hunan, China
🇨🇳Beijing Friendship Hospital, Capital Medical University, Beijing, Beijing, China
Safety, Tolerability, and Preliminary Efficacy of HRS-7450 Injection in the Treatment of Acute Ischemic Stroke: a Multi-center, Randomized, Double-blind, Double-dummy, Placebo-controlled Clinical Trial
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-06-07
- Last Posted Date
- 2024-12-10
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 62
- Registration Number
- NCT06447415
- Locations
- 🇨🇳
The First Affiliated Hospital of Sun Yat sen University, Guangzhou, Guangdong, China
A Study of Single and Multiple Doses HRS9531 Tablets in Healthy Subjects
Phase 1
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-05-30
- Last Posted Date
- 2024-06-21
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 92
- Registration Number
- NCT06435676
- Locations
- 🇨🇳
The Second Hospital Of Anhui medical University, Hefei, Anhui, China
A Multicenter, Randomized, Open, Parallel-designed Study to Evaluate the Efficacy and Safety of HRS-5635 Injection Alone or in Combination With Other Agents in Patients Treated for Chronic Hepatitis B
- First Posted Date
- 2024-05-22
- Last Posted Date
- 2024-06-24
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 165
- Registration Number
- NCT06425341
- Locations
- 🇨🇳
Nanfang Hospital, Guangzhou, Guangdong, China
To Compare the Efficacy and Safety of HRS9531 and Placebo in Subjects With Overweight or Obese
- First Posted Date
- 2024-05-02
- Last Posted Date
- 2024-05-30
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 540
- Registration Number
- NCT06396429
- Locations
- 🇨🇳
Zhongshan Hospital Affiliated to Fudan University, Shanghai, Shanghai, China
HRS9531 Injection in Obese Subjects With Heart Failure With Preserved Ejection Fraction
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-04-30
- Last Posted Date
- 2024-05-20
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 200
- Registration Number
- NCT06391710
- Locations
- 🇨🇳
Beijing Anzhen Hospital, Capital Medical University, Beijing, Beijing, China
A Study of HRS9531 in Participants With Impaired Kidney Function and Healthy Subjects
- First Posted Date
- 2024-02-07
- Last Posted Date
- 2024-03-06
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 32
- Registration Number
- NCT06246175
- Locations
- 🇨🇳
Chengdu Xinhua Hospital, Chengdu, Sichuan, China
A Trial of Intravenous HRS9432 in the Treatment of Subjects With Candidemia and/or Invasive Candidiasis
Phase 2
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-01-08
- Last Posted Date
- 2024-11-18
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 40
- Registration Number
- NCT06194201
- Locations
- 🇨🇳
The First Affiliated Hospital Of University Of South China, Hengyang, Hunan, China
A Trial of HRS-7450 in Chinese Healthy Volunteers
- First Posted Date
- 2023-10-17
- Last Posted Date
- 2023-10-17
- Lead Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Target Recruit Count
- 50
- Registration Number
- NCT06087094
© Copyright 2024. All Rights Reserved by MedPath